Radioiodine Therapy in Patients with Stage I Differentiated Thyroid Cancer
- Jacqueline Jonklaas ,
- David S. Cooper ,
- Kenneth B. Ain ,
- Thomas Bigos ,
- James D. Brierley ,
- Bryan R. Haugen ,
- Paul W. Ladenson ,
- James Magner ,
- Douglas S. Ross ,
- Monica C. Skarulis ,
- David L. Steward ,
- Harry R. Maxon , and
- Steven I. Sherman
Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, District of Columbia.
Johns Hopkins University School of Medicine, Baltimore, Maryland.
University of Kentucky Medical Center, Lexington, Kentucky.
Maine Medical Center, Portland, Maine.
Princess Margaret Hospital, Toronto, Canada.
University of Colorado at Denver and Health Sciences Center, Aurora, Colorado.
Johns Hopkins University School of Medicine, Baltimore, Maryland.
Genzyme Corporation, Cambridge, Massachusetts.
Massachusetts General Hospital, Boston, Massachusetts.
National Institutes of Health, Bethesda, Maryland.
University of Cincinnati Medical Center, Cincinnati, Ohio.
University of Cincinnati Medical Center, Cincinnati, Ohio.
University of Texas M.D. Anderson Cancer Center, Houston, Texas.
